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In all metazoans, the expression of group B HMG domain Sox transcription factors is associated with the earliest stages of CNS development.
In Drosophila, SoxNeuro (SoxN) is involved in dorso-ventral patterning of the neuroectoderm, and in the formation and segregation of
neuroblasts. In this report, we show that SoxN expression persists in a subset of neurons and glial cells of the ventral nerve cord at embryonic
stages 15/16. In an attempt to address SoxN function in late stages of CNS development, we have used a chromatin immunoprecipitation approach
to isolate genomic regions bound in vivo by SoxN. We identified several genes involved in the regulation of axon scaffolding as potential direct
target genes of SoxN, including beat1a, semaphorin2a, fasciclin2, longitudinal lacking and tailup/islet. We present genetic evidence for a direct
involvement of SoxN in axonal patterning. Indeed, overexpressing a transcriptionally hyperactive mutated SoxN protein in neurons results in
specific defects in axon scaffolding, which are also observed in transheterozygous combinations of SoxN null mutation and mutations in its target
genes.
© 2006 Elsevier Inc. All rights reserved.Keywords: SoxNeuro; Sox; HMG; Drosophila; Axon guidance; Transcriptional controlIntroduction
It is now well established that some of the early events of
central nervous system (CNS) development have been con-
served during metazoan evolution (Sasai, 2001). In both
vertebrates and Drosophila, the antagonistic activities of
secreted proteins, BMP4/chordin in vertebrates, and their
homologues Dpp/Sog in fly, result in the subdivision of the
neurogenic versus non-neurogenic regions of the ectoderm.
Among the targets of chordin/Sog action are the Sox genes,
encoding HMG domain transcription factors conserved during
evolution (Mizuseki et al., 1998; Cremazy et al., 2000). Genes of
the Sox family are involved during metazoan development in
regulating multiple events of cell fate determination and cell
proliferation/differentiation in a number of tissues, including
CNS, gut, testis, bones or eyes (Wegner, 1999; Kamachi et al.,
2000; Savare and Girard, 2002; Wilson and Koopman, 2002;⁎ Corresponding authors. Fax: +33 4 99 61 99 57.
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doi:10.1016/j.ydbio.2006.08.014Kondoh et al., 2004; Pevny and Placzek, 2005). Early
neurogenesis in vertebrates and invertebrates is associated
with the expression of group B Sox genes (see Savare and
Girard, 2002 and references therein). InDrosophila, the group B
Sox genes, SoxNeuro (SoxN) and Dichaete are required at early
steps of neurogenesis, in the dorso-ventral patterning of the
neuroectoderm and in the formation of neuroblasts (NBs)
(Buescher et al., 2002; Overton et al., 2002; Zhao and Skeath,
2002). Indeed, in SoxN null mutant, neuroectodermal cells fail to
be singled out as NBs, and delamination does not take place.
Since the expression of the proneural genes of the Achaete-Scute
complex (AS-C) is partially, but not completely, lost in SoxN and
Dichaetemutants, it was suggested that these Sox genes act both
upstream of, and in parallel to, the proneural AS-C genes in the
neuralizing pathway, likely in combination with the columnar
homeodomain genes vnd/ind/msh (Buescher et al., 2002;
Overton et al., 2002; Zhao and Skeath, 2002; Gomez-Skarmeta
et al., 2003).
Although the function of Sox genes during CNS develop-
ment starts to be elucidated, less is known on the target genes
they regulate. In the case of group B Sox proteins, only few
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(Tanaka et al., 2004), fgf4 (Ambrosetti et al., 1997), HoxB1 (Di
Rocco et al., 2001), UTF1 (Nishimoto et al., 1999), and crys-
tallin (Kamachi et al., 1995), and in Drosophila crystallin
(Blanco et al., 2005), slit (Ma et al., 1998) and vnd (Yu et al.,
2005). Several methods have been developed in the past few
years towards a genome wide identification of target genes
regulated by a given transcription factor, including DNA
microarrays, chromatin immunoprecipitation (ChIP), and ChIP
on chip studies combining both techniques, which was
essentially used in yeast (reviewed in Hanlon and Lieb,
2004). SoxN is also expressed later during embryogenesis in
the ventral nerve cord (VNC) and in the brain (Cremazy et al.,
2000, 2001; Buescher et al., 2002), suggesting a role in the CNS
late in embryogenesis. In an attempt to decipher the events
downstream of SoxN, we have used a chromatin immunopre-
cipitation procedure towards a genome wide identification of
genomic DNA regions bound in vivo by SoxN. This strategy led
to the identification of several genes that constitute potential
direct targets of SoxN transcriptional activity, a number of them
being involved in axon guidance/pathfinding. We show that
SoxN is expressed in a subset of neurons and glia within the
embryonic VNC. We also provide genetic evidence that SoxN is
involved in axonal patterning, likely through the direct
regulation of these genes in the embryonic VNC.Material and methods
Fly strains
All flies were raised on standard medium at 25°C. OregonR was used as wild
type. The following strains were used: UAS-SoxNK439R (Savare et al., 2005);
SoxNGA1192 (kindly provided by W. Chia); elav-GAL4, tup1, beat1a3Fas3E25,
lola00642, Sema2a03021 and Ubx101 (The Bloomington Stock Centre), islet-tau-
myc-GFP (kindly provided by S. Thor), eagle-Gal4 (kindly provided by A.
Garces), UAS-mCD8-GFP. GFP marked balancer chromosomes were used to
unambiguously identify mutant embryos.
Chromatin immunoprecipitation from Drosophila embryonic nuclei
Chromatin immunoprecipitation was performed essentially as already
described (Solano et al., 2003). Nuclei from OregonR embryo collection
enriched in late stages (stages 11 to 16) were prepared through sucrose gradient
centrifugation, then UV-irradiated for 4×2.5 min at 2.400 Joules using
Stratalinker. Nuclei were lysed, and the chromatin was prepared by centrifuga-
tion in CsCl containing buffer. Chromatin was sonicated, in order to obtain
genomic DNA fragments ranging in size from 200 bp to 3 kbp. For
immunoprecipitation, chromatin was first preincubated with protein A–agarose
(Sigma), for 4 h at 4°C, in buffer 1 (20 mMTris–Cl pH 7.5, 100 mMNacl, 1 mM
EDTA, 0.1% BSA). Pre-cleared chromatin was then incubated with either
preimmune serum or with rabbit anti-SoxN serum, and protein A–agarose beads
overnight at 4°C. Beads were washed 3 times in buffer 2 (10 mM Tris–Cl pH
7.5, 0.5 M LiCl, 0.1% SDS, 2% NP40), and 3 times in buffer 3 (50 mM Tris–Cl
pH 7.5, 50 mM NaCl). Bound chromatin was eluted from the beads with 1.5
volume of buffer 4 (10 mM Tris–Cl pH7.5, 100 mM NaCl, 1 mM EDTA, 4%
Sarcosyl, 2 mM AEBSF), for 30 min at 37°C, recovered by centrifugation and
dialyzed overnight at 4°C in buffer 5 (Tris 10 mM pH 7.5, EDTA 1 mM).
Immunoprecipitated chromatin was successively incubated with Klenow
(30 min at room temperature), RNase A (50 μg/ml for 30 min at 37°C), and
proteinase K (0.5 mg/ml for 3 h at 65°C, in the presence of 1% SDS). DNAwas
phenol/chloroform extracted, and ethanol precipitated in the presence of
glycogen. Linkers were prepared by mixing an equal volume of 5 μM solutionsof oligo 20 mer (5′ctgctcgaattcaagctt) and oligo 24 mer (5′P agaagcttgaattc-
gagcagtcag). Mixed oligos were annealed 3 min at 100°C, and renatured at room
temperature for 60 min. Precipitated chromatin was recovered in 14 μl H2O, and
ligated with linker (50 nM final) and T4 DNA ligase. The ligation reaction was
directly used for PCR amplification in the presence of oligo 20 mer (1 μM final).
The PCR amplified material was cloned in HindIII digested pBlueScript.
Individual clones from the SoxN immunoprecipitated DNAwere sequenced. For
in silico analysis, the position of the immunoprecipitated fragments was
determined by Blast using Release 4.1 of the Drosophila melanogaster genome.
Southern blot
DNA clones corresponding to intergenic and intronic fragments (see Result
section for details) were HindIII digested and run on 2% agarose gels. DNAwas
transferred to nitrocellulose membranes and processed for hybridization using
standard procedure. Membranes were first hybridized with 32P labeled
(Rediprime kit, Amersham) control library, and autoradiographed. After de-
hybridization, membranes were hybridized with 32P labeled SoxN library and
autoradiographed (as described in Solano et al., 2003). The two signals, SoxN
versus control, were compared for each of the clones tested.
Electrophoretic mobility shift assay
EMSA were performed essentially as described previously (Solano et al.,
2003). As protein source, we used purified GST and GST-SoxN (Bonneaud et
al., 2003). For super shift, rabbit polyclonal SoxN antibody was used (Cremazy
et al., 2001). Plasmids containing multimerized Sox binding sites (Bonneaud et
al., 2003) were used for control and competition experiments.
Embryo immunostaining and in situ hybridization
Whole-mount embryo immunostaining and in situ hybridization experi-
ments were performed using standard procedures (Tautz and Pfeifle, 1989). The
following primary antibodies were used: Cy3 conjugated mouse anti-HRP
(Jackson Immunoresearch), affinity purified rabbit anti-SoxN (Cremazy et al.,
2001), polyclonal rat anti-SoxN (Cremazy et al., 2000), mouse and rabbit anti-
GFP (Molecular probes), mouse anti-myc 9E10 (Santa Cruz), monoclonal anti-
repo, anti-Elav, anti-eve, anti-en (Developmental Studies Hybridoma Bank),
monoclonal anti-Ubx (a gift of J.M. Dura), polyclonal serum against Dichaete
(a gift of J. Nambu). Secondary antibodies used were biotinylated anti-rabbit
(Amersham) detected with avidin HRP (Vectastain), Alexa conjugated anti-
mouse and anti-rabbit (Molecular probes) and Cy2 or Cy3 conjugated anti-
mouse, anti-rat and anti-rabbit (Jackson Immunoresearch). Fillet preparations
of stages 15/16 embryos and subsequent immunostainings were performed
as described (Benveniste et al., 1998). Beat1a cDNA (kindly provided by
C. Goodman) was used to generate DIG labeled antisense RNA probe according
to manufacturer instruction (Roche).
Results
Isolation of genomic DNA fragments bound in vivo by
SoxNeuro
We have previously reported a ChIP-based approach to
isolate at a large scale Drosophila genomic DNA fragments
bound in vivo by the homeodomain transcription factor
Engrailed, which led to the identification of numerous Engrailed
direct target genes (Solano et al., 2003). ChIP is now routinely
used for the analysis of single, well-defined promoters, or at the
genome level in yeast, but only very few studies have reported
the use of this technique towards a genomewide identification of
target genes of transcription factors in animals. Reports where
the immunoprecipitated DNA were cloned and sequenced
include the studies on Engrailed (Solano et al., 2003) and
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al., 2004), BARX2 (Stevens et al., 2004) and E2F (Weinmann et
al., 2001) in humans. Thus, ChIP emerged very recently as a
possible reliable technique towards a genomewide identification
of direct target genes of transcription factors. In addition, recent
ChIP on chip studies, combining ChIP and DNA microarrays,
have been employed to analyze binding sites for several
transcription factors in humans, but these studies are still limited
by the availability of microarrays covering large genomic
regions (reviewed in Sikder and Kodadek, 2005).
The ChIP approach was applied here to the SoxN trans-
cription factor. As starting biological material, we used a wild-
type embryo collection enriched in late stages (stages 11 to 16),
aiming to isolate genes regulated by SoxN during neuronal
differentiation and axonal scaffolding. Briefly, the protocol
consisted in several steps: freezing of DNA/protein interactions
through UV treatment, preparation of chromatin, immunopre-
cipitation with anti-SoxN antibody, elution of co-immunopre-
cipitated DNA, PCR amplification, cloning and sequencing of
immunoprecipitated DNA fragments (detailed in Material and
methods). Two DNA libraries were prepared: one obtained with
anti-SoxN antibody (referred to as SoxN library), and one with
preimmune serum (referred to as Control library) (Fig. 1A). 249
clones were sequenced from the SoxN library, and were
mapped in the Drosophila genome to 125 distinct genomic
positions. Of these fragments, 36 (28.8%) corresponded to
intergenic regions, 28 (22.4%) to introns, 33 (26.4%) to exons
and 28 (22.4%) to repeat DNA. For our analysis, we considered
only intergenic and intronic fragments (64 fragments). To
determine whether the ChIP experiment gave significant targets
above random background, we verified how many of theseFig. 1. Southern blot hybridization test on 12 clones. (A) Schematic representation o
from chromatin prepared from embryonic nuclei, one with the anti-SoxN antibody, a
control (C). Only the individual clones from the SoxN library were sequenced. These
clones from the SoxN library. (B) The two 32P labeled libraries used were C: contr
Southern, and 25 were shown to be significantly enriched through ChIP (when the rat
The clones shown here correspond to the following genes (see also Table 1): trol
(1H12), beat1a (1H7), DNCad2 (2F1), Rs1 (2A4), CG12911 (4B12), rexin (1C11),fragments were indeed enriched through the anti-SoxN
immunoprecipitation. We performed Southern blot analysis
on these 64 clones, probing with either 32P labeled SoxN
library or control library. We considered that enrichment was
significant when the ratio SoxN/control was higher than 2,
which appeared to be the case for 25 clones out of the 64 tested
by Southern (shown in Fig. 1B is the result of the Southern
experiment for 12 clones). These 25 clones correspond to 26
genomic positions, 17 intronic and 9 intergenic. Indeed, one
chimera clone contained two fragments hitting the genome at
two distinct positions (Table 1, and on line Supplemental data
for the sequence and position of the clones). The length of the
recovered fragments varies from 44 bp to 359 bp. It is important
to note that 11 clones out of these 25 contain an endogenous
HindIII restriction site at one (or both) extremity. The linker
used to PCR amplify the fragments contained an HindIII site,
and this enzyme was used to digest the PCR amplified DNA for
cloning into pBlueScript. Thus, for these 11 clones, the initial
immunoprecipitated fragments were longer, and a shorter DNA
was cloned after HindIII restriction. We found that a majority of
these fragments (17/25) are located within introns, thus in
regions outside of, and sometimes far away from, gene
promoters. This observation was already made by us (Solano
et al., 2003) and others (Matyash et al., 2004; Stevens et al.,
2004), and suggests that these regulatory regions might
function through long-range interactions perhaps involving
chromatin looping. In addition, although only intronic and
intergenic regions were analyzed here, it remains possible that
sites mapping to exons (see on line Supplemental data for
sequence) would also be candidates for potential regulatory
activities. This is particularly interesting in the case of SoxN,f the ChIP experiment and control. Two immunoprecipitations were performed
nd one with preimmune serum, which led to two DNA libraries, SoxN (S) and
two libraries were also 32P labeled, and used in Southern experiment to probe 64
ol and S: SoxN. A total of 64 clones from the SoxN library were analyzed by
io signal obtained with the S probe/signal obtained with the C probe was over 2).
/CG13758 (4C9), Fas2 (1A8), CG1631/CG1504 (3D5), PLC21C (1A4), Ubx
Gsα60A (3D6), bnl (1E10).
Table 1
Listing of SoxNeuro target genes
Cytology Candidate gene(s) Gene ontology Length (bp)
Immunoprecipitated fragments in intronic regions
4B1–3 Fasciclin 2 (a) (Fas2) Neural cell adhesion; axon pathfinding 49
21B8-C1 PLC21C Enzyme (phospholipase C), GPCR signaling pathway 44
35E2 Beat1a Neural cell adhesion; axon pathfinding 109
36D3 Cadherin N2 Neural cell adhesion? axon pathfinding? 57
44B7 Rs1 Enzyme (RNA helicase) 170
46F9 CG12911 Unknown 130
46F9–47A1 Rexin/CAP Vinculin binding; expressed in embryonic sensory nervous system 215
47A11–47A13 Longitudinals lacking (lola) Transcription factor; axon pathfinding 138
53C6–7 Semaphorin2a (sema2a) Neural cell adhesion; axon pathfinding 199
55B12 CG5719 Enzyme (guanylate cyclase), GPCR signaling pathway 170
57B9–12 CG30296 Unknown 359
60A12–13 Gsα60a G protein; GPCR signaling pathway; learning and memory 58
66D12–15 CG32030 Actin binding; expressed in midline glia 168
89D6–9 Ultrabithorax (Ubx) Transcription factor; NB/neuron segmental identity 146
92B2–3 Branchless (bnl) FGF receptor 205
96A7 CG6643 (a) Unknown 248
100A6 CG12045 Unknown 162
Immunoprecipitated fragments in intergenic regions
3A4–6 CG13758 Neuropeptide receptor, GPCR signaling pathway 338
Trol/perlecan Heparan sulfate proteoglycan; larval NB division
13B6 CG15032 (a) Unknown 63
gce Transcription factor
19C4 CG1631 Unknown 62
CG1504 Receptor
34C6 Rsu-1 Small GTPase interacting protein 135
CG18507 Unknown
37B5 Tailup/islet (tup) Transcription factor; neuronal fate specification; axon pathfinding 60
CG18397 Unknown
62A12 CG12011 Unknown 391
CG13930 Enzyme (dynein ATPase)
68A4 Mocs1 Molybdopterin cofactor synthesis 44
CG6310 Unknown
91B3–4 CG7691 (a) Nucleic acid binding 347
Fruitless (fru) Transcription factor; neuronal fate specification; axon pathfinding
92F8–10 CG31205 Enzyme (protease) 182
Oamb Amine receptor; learning and memory
Given are the cytological position, as described in Flybase (http://flybase.bio.indiana.edu/), the length of the fragments, the candidate target gene(s), their molecular
function according to Gene Ontology, and when available their involvement in CNS development. For genes of unknown function, CNS expression is given when
available (data extracted from Flybase). (a) Corresponds to chimeric fragments, containing two fragments mapping at different genomic positions, that are likely to
result from the cloning procedure. GPCR: G-protein-coupled receptor. NB: neuroblast. See also Supplemental data available on line, containing the sequence of the
immunoprecipitated clones, their position within each genes, and the presence of Sox consensus binding sites.
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bending, which could be important in the formation of higher
order chromatin structures (Kamachi et al., 2000; Wilson and
Koopman, 2002).
Identification of SoxNeuro target genes
To assign for potential SoxN target genes, we considered a
single target gene when the fragment was located within an
intron of this gene, and the two surrounding genes in the case
of intergenic fragments, regardless the distance to the
transcription start. The listing of potential SoxN target genes
is given in Table 1. These genes can be categorized into several
classes, encoding transcription factors (lola, Ubx, fruitless,
gce, tailup/islet), enzymes (PLC21C, Rs1), receptors and
associated proteins (Gsα60A, branchless, Oamb), neural celladhesion molecules (fas2, beat1a, DNCad2, sema2a, trol). In
the case of intronic fragments, it is interesting to note that
among the known candidate target genes, most of them (8/11)
are involved, or at least specifically expressed, in late steps of
CNS development. Several of the isolated SoxN target genes
are involved in axonal patterning, a process in which axons are
guided along specific pathways by attractive and repulsive cues
in the extracellular environment (reviewed in Cooper, 2002;
Dickson, 2002; Huber et al., 2003). Among these, beat1a
encodes a secreted protein of the immunoglobin superfamily,
which functions as an anti-adhesive factor secreted by motor
neuron growth cones at defasciculation choice points (Fam-
brough and Goodman, 1996). Fas2 encodes a protein of the
immunoglobin superfamily expressed in longitudinal axons,
which displays adhesive function in axon fasciculation
(Grenningloh et al., 1991) and in growth cone guidance (Lin
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closely related to CadN. Although DNCad2 function in neural
cell adhesion has not been examined, one can speculate a
function in axon patterning like CadN (Iwai et al., 1997). In
support of this, we found thatDNCad2 expression was restricted
to the CNS at embryonic stage 16 (data not shown). Sema2a
encodes a transmembrane protein expressed in a subset of VNC
neurons, exhibiting a chemorepulsive activity that deflects axons
away from inappropriate regions (Huber et al., 2003). Lola
encodes a BTB-POZ transcription factor involved in establish-
ing the pattern of longitudinal axon projections, both by
inhibiting growth across the midline and promoting axon growth
longitudinally, likely through the regulation of multiple
independent guidance genes (Crowner et al., 2002). Tup (also
named Islet) encodes a LIM-homeobox transcription factor
expressed in interneurons and in post mitotic motor neurons
projecting to ventral targets, and involved in motor neuron
identity (Thor and Thomas, 1997) and axon pathfinding through
the regulation of guidance genes such as beat1c (Certel and
Thor, 2004). Ubx encodes an homeobox transcription factor
involved in NB segmental identity (reviewed in Doe and Scott,
1988), that also appears to be important for axon patterning in
the VNC (Merritt and Whitington, 2002). Fruitless encodes a
BTB-POZ transcription factor involved in multiple develop-
mental processes, including axon fasciculation in the embryonic
CNS (Song et al., 2002). Therefore, these genes affect axon
guidance/pathfinding at different levels, transcriptional or
extracellular, acting either as repellent or attractive cues.
In vitro binding of SoxNeuro to immunoprecipitated DNA
fragments
In vitro, vertebrate Sox proteins bind DNA to the degenerated
consensus sequence A/T
A/TCAA
A/T (Pevny and Lovell-Badge,
1997). When examining Sox binding sites in regulatory
sequences of known SoxB target genes, it appears that all fit to
this consensus, with sometimes a degree of divergence in the
nucleotides flanking the ACAA core (Kamachi et al., 1995;
Ambrosetti et al., 1997; Nishimoto et al., 1999; Di Rocco et al.,
2001; Tanaka et al., 2004; Blanco et al., 2005). Drosophila
Dichaete also binds this type of consensus in vitro (Ma et al.,
1998). SoxN efficiently binds this consensus in vitro, as
revealed by electrophoretic mobility shift assays (EMSA)
using 7SOX probe, containing seven AACAAAG sites (Fig.
2A and Bonneaud et al., 2003). Competition with increasing
quantities of cold 7SOX probe, as well as incubation with anti-
SoxN antibody confirmed the specificity of the binding (Fig.
2A). We next analyzed by EMSA the ability of SoxN to bind
the immunoprecipitated DNA fragments. SoxN binds the
1H12 fragment, localized in an Ubx intron (Fig. 2B). Again,
the specificity of the binding was demonstrated with
incubation with cold 7SOX probe, which competed for
SoxN binding to 1H12, and with incubation with SoxN
antibody, which induced super shift of the 1H12-SoxN
complexes. In both cases, GST protein alone did not form
complex with the radiolabeled probe (not shown). Similar
observations were made for the following fragments: 4A7(localized between tup and CG18397) and 1H7 (localized in
beat1a intron). In these two cases, specific complexes were
observed with GST-SoxN protein and not with GST alone, and
the formation of these complexes was competed, completely or
partially, with the cold 7SOX probe (Figs. 2C, D). Together,
these data demonstrate that SoxN can specifically bind in vitro
to several of the DNA fragments isolated by ChIP. This
binding is likely to involve the A/T
A/TCAA
A/T consensus, since
it is present in most of the immunoprecipitated fragments (see
Supplemental data available on line). Indeed, 9 out of 17
intronic fragments, and 8 out of 9 intergenic fragments,
contain one or more typical Sox consensus binding sites. This
is for example the case for the 1H12 and 4H7 fragments,
containing respectively two and one Sox binding sites. As
mentioned before, a certain degree of divergence is observed
in the nucleotides flanking the ACAA core. It is noteworthy
that of the 8 intronic fragments that do not contain the typical
Sox consensus binding site, 6 contains the ACAA core, among
which is the 1H7 fragment (see Supplemental data available on
line).
SoxNeuro is expressed in a subset of neurons and glia in the
ventral nerve cord
SoxN has been implicated in the formation of NBs, upstream
of the Achaete-Scute complex genes (Buescher et al., 2002;
Overton et al., 2002). SoxN is expressed early during
embryogenesis in the neuroectoderm and in forming NBs, and
later in the VNC and the brain (Cremazy et al., 2000, 2001;
Buescher et al., 2002). SoxN immunostaining in late embryonic
stages revealed a reiterated pattern in a subset of cells within the
VNC, around 25–30 per abdominal segment (Figs. 3A–C). For
a closer examination of SoxN expression, immunostainings
were performed on dissected VNC from embryos at stages 15/
16. Double immunostaining with the neuronal specific marker
Elav showed that several of the SoxN-positive cells are neurons
(Figs. 3D–F). Double immunostaining with the glia specific
marker Repo (Halter et al., 1997) revealed that SoxN is
expressed in several glial cells, 6–7 per abdominal hemiseg-
ment (Figs. 3G–J). Based on their shape and location (Ito et al.,
1995), the medial most cells might correspond to MM-CBG
(medial most cell body glia, two in each thoracic hemineur-
omere and one in abdominal hemineuromere), while the more
laterally located might correspond to SPG (subperineurial glia).
Together, these experiments demonstrate that SoxN is expressed
in a restricted population of neurons and glia within the VNC.
This suggests that in addition to its early function within the
neuroectoderm, SoxN might also be required at late steps of
embryonic neurogenesis, in agreement with the finding that
axon patterning genes are potential SoxN target genes.
The nature of SoxN expressing neurons was investigated in
immunostaining experiments with several neuron specific
markers. At stage 16, the expression in the VNC of the Sox
gene Dichaete is restricted to two clusters of cells in each of the
thoracic segments and a single cell in each of the abdominal
segments (Soriano and Russell, 1998 and Fig. 3K). Since
Dichaete and SoxN were shown to function synergistically
Fig. 2. In vitro binding of SoxN to immunoprecipitated fragments. (A) Binding of SoxN to a probe containing 7 multimerized binding sites for proteins of the Sox
family (7SOX probe) (lane 1). This binding is competed with increasing quantities of the same cold probe (lanes 2–4, respectively 10-, 20- and 30-fold molar excess).
The complexes are super shifted with SoxN antibody (lane 5). (B) Binding of SoxN to the immunoprecipitated fragment 1H12 (146 bp in length, localized in Ubx
intron). Specific retarded complexes are observed in the presence of GST-SoxN (lane 1), the formation of which is competed with cold 7SOX probe (lanes 2–4,
respectively 10-, 20- and 30-fold molar excess). The complexes are super shifted with SoxN antibody (lane 5). (C–D) Binding of SoxN to the immunoprecipitated
fragments 4A7 (localized between tup and CG18397) and 1H7 (localized in beat1a intron). Binding to the 32P labeled DNA probe was tested in the following
conditions: incubation with GST-SoxN (lane1) or GST (lane 3), competition of GST-SoxN binding with cold 7SOX probe (20-fold molar excess, lane 2), 4A7 or 1H7
probes alone (lane 4). Note that in the case of 1H7, competition with 7SOX is incomplete, suggesting that the affinity of SoxN for this fragment is higher. In all cases,
the retarded DNA/SoxN complexes are indicated with asterisks.
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genes were co-expressed later in the VNC. We found that few
cells co-expressed Dichaete and SoxN proteins in thoracic
segments (3/4 per hemisegment), while no co-localization was
observed in abdominal segments (Figs. 3K–M). At stage 16,
eagle is only expressed in 4 neurons of the 7-3 lineage: three
interneurons and one ipsilaterally projecting motor neuron (7-
3M, also called GW) (Dittrich et al., 1997). SoxN immunostain-
ing in an eagle-Gal4; UAS mCD8-GFP embryo revealed that
SoxN and eagle are co-expressed only in 7-3M/GW motor
neuron at stage 16 (Figs. 4A–C). We have not looked at earlier
developmental stages, when eagle is also expressed in neurons
of the NB2-4, NB3-3 and NB6-4 lineages (Dittrich et al., 1997).
Since SoxN is absolutely required for the formation of lateral
eagle-expressing NBs (Buescher et al., 2002; Overton et al.,
2002), it is possible that more neurons co-express eagle and
SoxN from stages 13 to 14. Double staining experiments with
SoxN, even-skipped and engrailed antibodies revealed that
SoxN staining was mutually exclusive with both eve (Fig. 4K)
and en staining (Fig. 4J). This shows that SoxN is absent from
the following eve-expressing neurons: aCC, pCC, RP2, CQ and
E2, and in the en neurons derived fromNB1–1,MNB, and row 6and 7 NBs. Finally, we investigated whether SoxN was co-
expressed with one of its potential target gene, tailup/islet. By
stage 16, tailup/islet is expressed in a subset of ventrally
projecting motor neurons and interneurons (Thor and Thomas,
1997). SoxN immunostaining in an islet-tau-myc-GFP embryo
revealed that SoxN and tailup/islet are co-expressed in each
abdominal segment in a pair of neurons on each side of the
midline, and in an additional centrally located neuron that might
correspond to dopaminergic neuron (Figs. 4D–F). SoxN is also
co-expressed with two other of its potential target genes, Ubx
and Beat1a. Indeed, while only few beat1a-expressing motor
neurons are stained with SoxN antibodies (Figs. 6A–B′), several
of the SoxN expressing cells within the VNC at stage 15/16 also
express Ubx (Figs. 4G–I).
SoxNeuro involvement in axonal patterning
Based on SoxN expression in neurons and glia, and the
identification of target genes involved in axon guidance/
pathfinding, it is likely that SoxN function is also required at
later stages of neurogenesis when axon targeting takes place. In
the Drosophila VNC, most axons are organized in a ladder-like
Fig. 3. SoxN is expressed in a subset of neurons and glia within the VNC. (A–B) Whole-mount SoxN immunostaining in stage 16 embryos, highlighting SoxN
expression in the VNC, the PNS and the epidermis (ep). SoxN is expressed in a subset of cells in a reiterated segmental pattern in the VNC. Note that staining in the
brain is not on the same focal plane. (B) Higher magnification focusing on VNC, showing staining pattern in thoracic (T) and abdominal (A) segments. (C–J) Fillet
preparation of wild-type stage 15/16 embryos, immunostained for SoxN and HRP (panel C), SoxN and Elav (panels D–F), SoxN and repo (panels G–J), SoxN and
Dichaete (panels K–M). All embryos are oriented anterior up. All images were obtained by confocal microscopy. (D–F) Each panel is a stack of 5 confocal slices
(0.8 μM thick) focusing on one segment, showing that SoxN (green in panel D) is expressed in neurons, as revealed with Elav staining (red in panel E). (G–J) Merge
images of SoxN (green) and repo (red) staining. All images are stack of 5 confocal slices (0.8 μM thick) focusing on two segments on the same VNC (thoracic T3 and
abdominal A1), from ventral-most (G) to dorsal-most (J). SoxN is detected in a limited subset of Repo-positive glia. Note that SoxN is absent from most longitudinal
Repo-positive glia (not in the same focal plane). (K–M) Each panel is a stack of 10 confocal slices (0.7 μM thick), focusing on thoracic (T3) and abdominal (A1)
segments. SoxN and Dichaete are co-expressed in 3/4 cells per thoracic hemineuromere (marked by arrowhead), while SoxN is absent from the single cell per
abdominal hemineuromere expressing Dichaete.
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Fig. 4. SoxN expression in VNC neurons. SoxN immunostaining was analyzed by confocal microscopy in dissected VNC from embryos at stage 16. All embryos are
oriented anterior up. (A–C) Each image is a stack of 5 confocal slices, 0.6 μM thick. SoxN (visualized with anti-SoxN antibody in red, panel A) and eagle (eagle-Gal4;
UASmCD8-GFP, visualized with anti-GFP in green, panel B) are co-expressed in a pair of GWmotor neurons in each segment (marked with arrowheads). (D–F) Each
image is a stack of 5 confocal slices, 0.6 μM thick. SoxN (visualized with anti-SoxN in red, panel D) and islet/tailup (islet-tau-myc-GFP, visualized with anti-myc in
green, panel B) are co-expressed in one pair of neurons in each segment (marked with arrowheads), and one cell located at the midline, likely a dopaminergic neuron
(marked with asterisks). (G–I) Each image is a stack of 5 confocal slices, 0.8 μM thick. SoxN (visualized with anti-SoxN in green, panel G) and Ubx (visualized with
anti-Ubx in red, panel H) are co-expressed in several cells. (J–K)Merge images of SoxN (red) and even-skipped or engrailed (green) immunostainings. Each image is a
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and two longitudinal connectives, connecting individual
neuromeres along the antero-posterior axis (Fig. 5A). Embryos
lacking SoxN show defects in the axon scaffolding in the VNC,
including disruption of the longitudinal axon fascicles, and
strong defects in the anterior and posterior commissures (Fig.
5B). Since SoxN function is absolutely required in NB
formation upstream of the proneural genes, this phenotype
could result, at least in part, from the absence of formation of
several NBs (Buescher et al., 2002; Overton et al., 2002). Thus,
due to its early function in NB formation, it was not possible to
analyze SoxN late function in neurons by using SoxN null
mutants, because the defects in CNS scaffolding might be
interpreted as a failure of NBs to be formed and to give rise to
neurons. Therefore, we decided to use an alternative strategy,
consisting in overexpressing a mutated form of SoxN protein
interfering with endogenous SoxN function. Indeed, we
recently described that SoxN was SUMO modified on Lysine
439, resulting in the repression of its transcriptional activity
(Savare et al., 2005). In vivo, overexpression in embryos of a
SUMO-deficient and transcriptionally hyperactive SoxN pro-
tein (in which the SUMO acceptor Lysine K439 was mutated to
Arginine) results in defects in CNS development (Savare et al.,
2005). To analyze the function of SoxN in neurons, we used the
UAS-GAL4 system to drive the expression of this mutated
SoxNK439R protein in all neurons using Elav-Gal4. This
resulted in specific defects in the axon scaffolding in the VNC,
including defects in the commissures (AC and PC are often
fused, with higher diameter than in wild type), thickening of
the longitudinal connectives, and tangles at the segmental
boundaries, suggesting that many axons project inappropriately
(Fig. 5C). By contrast, the CNS architecture shows wild-type
appearance when overexpressing the wild-type SoxN proteinFig. 5. SoxN involvement in axonal patterning. Cy3 conjugated anti-HRP whole-mou
(A) OregonR. Ladder like neuronal structure of the VNC, with anterior commissur
SoxNGA1192 homozygous embryos, axonal architecture is severely perturbed, with fus
Defects include axonal tangles (arrowheads), thickening of the LC, and partial fusi
appearance. (E) lola00642/SoxNGA1192 transheterozygous embryos are characterizedwith Elav-Gal4 driver (Fig. 5D), suggesting that the pheno-
types rather resulted from perturbation of endogenous SoxN
function with SoxNK439R in neurons (acting as a dominant
negative or hyperactive allele—see below), than simply
overexpression of SoxN. This was confirmed by genetic
interaction experiments in transheterozygous combinations of
both SoxN null mutation and mutations in its target genes
involved in axonal pathfinding. We reasoned that lowering
SoxN dose (in a SoxN−/+ embryo) should result in a decrease in
the expression of its target genes, eventually leading to
synthetic lethality and visible axonal scaffolding phenotypes
in embryos mutated in only one copy of its target genes.
Transheterozygous combinations of SoxN/target gene muta-
tions show several degree of synthetic lethality ranging from
100% (SoxN/+; Ubx/+), 43.2% (SoxN/beat1a), 19.8% (SoxN/
lola), to 17.8% (SoxN/tup). By contrast, no lethality was
observed in heterozygous combinations of SoxN/+, and
surprisingly of SoxN/Sema2a (Table 2). This lethality was
correlated with defects in axon scaffolding, such as fusion of
commissures, axonal tangles, disruption and/or reduction of
longitudinal connectives, as revealed by anti-HRP immunos-
taining in SoxN/lola (Fig. 5E) and SoxN/beat1a embryos (Fig.
5F), while we observed no CNS defect in their sibling single
heterozygous (data not shown). For Ubx/SoxN mutant, no stage
16 embryos were observed, suggesting that lethality period
occurred earlier. These results show that SoxN and two of its
potential target genes, lola and beat1a, genetically interact in
the formation of the CNS axonal architecture.
Finally, we analyzed whether modulating SoxN expression
could result in perturbation in the expression of one of its
downstream target genes, beat1a. Beat1a expression starts at
stage 12 in early born motor neurons, and by stage 14 it is
expressed in all motor neurons (Fambrough and Goodman,nt immunostaining performed on stage 16 embryos. The genotypes are indicated.
e (AC), posterior commissure (PC), and longitudinal connectives (LC). (B) In
ion of the commissures and gaps in LC. C: elav-GAL4/+, UAS-SoxNK439R/+.
on of commissures. (D) elav-GAL4/+, UAS-SoxN/+. The VNC is wild type in
by axonal tangles (arrowheads), thinner LC and commissures. (F) In beat1a3
Table 2
Analysis of synthetic lethality in transheterozygous mutants
SoxNGA1192/CyO-GFP
males crossed to
Lethality of
transheterozygous
mutants (%)
Number of
individuals
screened
Females
+/CyO-GFP 0 222
lola00642/CyO-GFP 19.8 531
beat1a3FasIIIE25/CyO-GFP 43.2 393
Ubx101/Ser-GFP 100 120
Sema2a03021/CyO-GFP 0 210
Tup1/CyO-GFP 17.8 484
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15/16 (Figs. 6A, B–B′). We found that beat1a expression was
severely perturbed, although not abolished, in SoxN mutant
embryos (Fig. 6D). As discussed earlier, this could result from
early defects in NB formation, leading to an absence of some
of the beat1a expressing neurons. As shown before (Fig. 5 and
Savare et al., 2005), the hyperactive SUMO-deficient K439R
SoxN mutant is able to some extent to interfere with SoxN
activity and to induce defects in axonal architecture. We
observed that pan-neuronal expression of this mutant form was
also able to perturb beat1a expression. Indeed, ectopic beat1aFig. 6. SoxN regulates beat1a expression. (A–B) beat1a and SoxN are co-expressed i
beat1a in situ hybridization (cytoplasmic, blue) in stage 15 (A) and 16 (B) embryos,
neurons co-expressing SoxN and beat1a. Panel B′ is a higher magnification of pane
beat1a expression in SoxN-deficient or overexpressing embryos. beat1a expression w
E) OregonR, (D) SoxNGA1192/SoxNGA1192, (F) elav-GAL4/UAS SoxN K439R, (G)
three abdominal segments. Shown are stage 12 (C, D) and stage 16 (E–G) embryos. P
respectively. All embryos are oriented anterior up.expression was observed in Elav-GAL4/UAS SoxN K439R
embryos (Figs. 6F–F′). In addition, we observed that beat1a
staining appeared lower than in wild type in several cells (Fig.
6F′). None of these effects were observed when driving the
wild-type SoxN form in neurons (Fig. 6G), suggesting that the
modulation of beat1a expression is likely to result from
perturbation of endogenous SoxN activity rather than simply
SoxN overexpression. The function of Sox proteins involves
partnering with specific co-factors to achieve maximal and
specific transcriptional regulation (Kamachi et al., 2000;
Wilson and Koopman, 2002; Blanco et al., 2005). The
K439R SoxN protein is transcriptionally hyperactive, as
shown in cell transfection assays (Savare et al., 2005), and
thus could to some extent bypass the requirement of co-factors
to interfere with endogenous beat1a expression, and other
target genes, leading to specific defects in CNS development.
As these effects are not observed with overexpression of the
endogenous SoxN form, this suggests that the phenotypic
effects of SoxNK439R expression do not simply result from
SoxN expression, but rather from the ability of SoxNK439R to
modulate to some extent endogenous SoxN function (acting
for example as a dominant negative or inversely as a
hyperactive allele). Collectively, these data support a direct
role for SoxN in the regulation of beat1a expression,n few motor neurons. Whole-mount SoxN immunostaining (nuclear, brown) and
focusing on three abdominal segments. Arrowheads point to some of the motor
l B. (C–G) beat1a expression is under SoxN regulation, as shown by analyzing
as monitored by in situ hybridization in embryos of the following genotype: (C,
elav-GAL4/UAS SoxN. Images in panels C and D focus on beat1a staining in
anels E′ and F′ are higher magnification of the embryos shown in panels E and F,
540 F. Girard et al. / Developmental Biology 299 (2006) 530–542consistent with the co-expression of SoxN and beat1a in some
motor neurons.
Discussion
We provide here molecular and genetic evidence for a novel
role of SoxN in axonal patterning, likely through the direct
regulation of several genes involved in axon guidance/
pathfinding, the identity of which was determined by chromatin
immunoprecipitation. We have provided evidence that SoxN is
expressed in a limited subset of neurons and glia, and is co-
expressed in a subset of neurons with at least three of its target
genes, beat1a, Ubx and tailup. EMSA experiments showed that
SoxN efficiently and specifically binds in vitro to some of the in
vivo immunoprecipitated fragments, including those localized
in intron (Ubx, beat1a) and intergenic region (tup/CG18397).
SoxN and two of its target genes, lola and beat1a, genetically
interact in the developing CNS, since specific defects in the
axonal architecture are observed in transheterozygous embryos.
Finally, interfering with the endogenous SoxN function through
the neuronal specific overexpression of a mutated SUMO-
deficient and transcriptionally hyperactive form of SoxN
resulted in axon guidance phenotypes. Collectively, these data
strongly support a role for the SoxN transcription factor in the
regulation of axonal architecture. Intricate relationship between
neurons and glia is required during axonal patterning (Edenfeld
et al., 2005). As described here, SoxN is expressed in subset of
both neurons and glia, and could thus potentially contribute to
axonal patterning by regulating, positively or negatively, genes
expressed by these two cell types. Although the identification of
molecules involved in axon guidance/pathfinding has received
much attention in the past years, the transcriptional control of
this process remains largely unsolved. Several transcription
factors expressed in post-mitotic neurons have been shown to
regulate axon guidance programs to select specific axon
pathways to reach their targets, such as the LIM-homeodomain
factors apterous and tailup/islet, which are believed to regulate
the expression of guidance cues and their receptors (Shirasaki
and Pfaff, 2002; Certel and Thor, 2004). To date, SoxN has been
involved in dorso-ventral patterning of the neuroectoderm and
NB formation in embryonic CNS (Buescher et al., 2002;
Overton et al., 2002; Gomez-Skarmeta et al., 2003), and in eye
development (Blanco et al., 2005). Our data argue for a novel
function of SoxN in controlling the formation of CNS
architecture through the direct regulation of genes required for
axon pathfinding at multiple levels. Indeed, these genes encode
proteins acting as pro-adhesive (fas2, DNCad2) and repellent
cues (beat1a, Sema2a), and transcription factors expressed in
subsets of neurons (tup, Ubx, fru), which in turn can regulate
specific axon guidance programs.
Our EMSA experiments showed that the immunoprecipi-
tated DNA are efficiently bound in vitro by SoxN.
A/T
A/TCAA
A/T consensus sequences are present in most of
these immunoprecipitated fragments (see Supplemental data on
line). Further work will be required to determine to which site(s)
SoxN binds within these fragments, and whether a more defined
consensus emerges. SoxN binds the A/T
A/TCAA
A/T consensussequence in vitro (this study), and transactivates a reporter gene
placed downstream of multimerized consensus sites in cell
transfection assays (Bonneaud et al., 2003), as observed for
many other Sox. Nevertheless, it has been observed that gene
regulatory elements are responsive in vivo to only a small subset
of the Sox family, implying that regulatory mechanisms exist to
permit selective binding and transcriptional regulation in vivo.
Among these mechanisms is the ability of Sox to interact with
specific transcription factors, which often bind DNA to adjacent
sites, leading to synergistic and context-dependent transcrip-
tional regulation (Kamachi et al., 2000; Wilson and Koopman,
2002). The multiple functions of SoxN are likely to involve
differential partnership of SoxN with specific transcription
factors. Indeed, it was suggested that SoxN function in the
neuroectoderm might involve direct association with the
columnar homeodomain transcription factors Vnd/Ind/Msh to
regulate AS-C gene expression (Buescher et al., 2002; Overton
et al., 2002; Zhao and Skeath, 2002; Gomez-Skarmeta et al.,
2003). SoxN also associates with the paired type homeodomain
transcription factor DPax2 to regulate crystallin expression in
the cone cells (Blanco et al., 2005). Interestingly, we found in
several fragments, including those identified in lola and Sema2a
introns, consensus binding sites for POU-homeodomain tran-
scription factors, which are known to be involved in axon
pathfinding (Certel et al., 2000; Certel and Thor, 2004) and to
specifically interact with Sox factors in different species
(Kamachi et al., 2000). Furthermore, the Sox factor Dichaete
was shown to co-regulate with the POU protein Drifter the CNS
midline expression of the Slit gene, involved in axon guidance at
the midline (Ma et al., 2000). Thus, it will be interesting to
determine whether the combinatorial activity of SoxN/POU
factors contribute to the differential regulation of these genes in
the CNS.
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